Clinical Trial

Pharmacokinetics and Safety of GH001 Delivered Via a GH001 Aerosol Delivery System in Healthy Subjects

Not Yet Recruiting Phase 1
View on ClinicalTrials.gov →
Record status
This record was last updated April 20, 2026 (before its estimated May 2026 completion). Its status may not reflect the trial's current state.
Summary
The primary objectives of this trial are to determine the pharmacokinetic (PK) profile and the safety and tolerability of GH001 delivered via a proprietary aerosol delivery device in healthy subjects after single-dose administration.
Trial Details
NCT Number NCT07540494
Lead Sponsor GH Research Ireland Limited
Conditions Healthy Adult
Enrollment 12 participants
Start Date 2026-04
Primary Completion 2026-05 (estimated)
Study Completion 2026-05 (estimated)
Updated on ClinicalTrials.gov 2026-04-20